[MR findings of the inflammatory demyelinating diseases of the central nervous system].
ADEM
MOG antibody-associated disease
MS
NMOSD
Journal
Rinsho shinkeigaku = Clinical neurology
ISSN: 1882-0654
Titre abrégé: Rinsho Shinkeigaku
Pays: Japan
ID NLM: 0417466
Informations de publication
Date de publication:
22 Jul 2023
22 Jul 2023
Historique:
medline:
23
10
2023
pubmed:
3
7
2023
entrez:
2
7
2023
Statut:
ppublish
Résumé
When demyelinating disease of the central nervous system is suspected, MR examination has mainly three roles: diagnosis, imaging biomarkers, and early detection of adverse effects from therapeutic agents. Because the location, size, shape, distribution, signal intensity, and contrast pattern of the brain lesions on MRI vary depending on the demyelinating diseases, careful attentions are required to assess the differential diagnosis and activity. It is necessary to be familiar with not only typical imaging findings but also atypical findings of demyelinating disease since minor neurological findings and nonspecific brain lesions may lead to misdiagnosis of demyelinating disease. This article reviewed the characteristics of MRI findings and showed recent topics of the demyelinating diseases.
Identifiants
pubmed: 37394489
doi: 10.5692/clinicalneurol.cn-001855
doi:
Substances chimiques
Biomarkers
0
Myelin-Oligodendrocyte Glycoprotein
0
Autoantibodies
0
Types de publication
Review
English Abstract
Journal Article
Langues
jpn
Sous-ensembles de citation
IM